Health Care: Drugs

Momenta Pharmaceuticals Inc (MNTA: NASDAQ)

$20.37 0.15 | 0.74%
08/28/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 20.22
52 Week High 25.56
52 Week Low 9.38
Avg. Daily Vol. (Mil) 0.89
Beta (3 year) 1.64
Share Related Items
Mkt Cap (Mil) 1,391.43
Shares Out (Mil) 68.81
Float (Mil) 50.19
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 14.00
Current Ratio 14.10
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 16.57
Price/Book 3.34
Price/Cash Flow -23.60
Per Share Data
Earnings -1.30
Sales 1.22
Book Value 6.05
Cash Flow -0.86
Business Summary
Momenta Pharmaceuticals Inc is a biotechnology company. It is engaged in developing generic versions of complex drugs, biosimilars and novel therapeutics for oncology and autoimmune disease.
General Information
675 West Kendall Street
Cambridge, MA 02142
www.momentapharma.com
Industry : Drugs
Sector: Health Care
Employees: 256
CEO: Craig A. Wheeler
Short Interest
Current Month (Mil) 7.67
Previous Month (Mil) 7.54
Short Interest Ratio (Days) 10.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -14.90
Return on Investments -16.60
Profitability
Gross Margin n.a.
EBIT Margin -94.60
Profit Margin -82.40

Portfolios with MNTA

Latest MNTA Headlines from TheStreet

More Financial News for MNTA

Press Releases for MNTA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter